CD9 and acute myeloid leukemia: CD9 has also been reported as a potential marker of MRD testing with increased expression in both leukemic stem cells and leukemic blasts,9,26 which remains stable after therapy.24 Coustan-Smith et al24 found that CD9 was significantly overexpressed in AML compared to normal (P < .001).